Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
D-cycloserine for Chronic Refractory Low Back Pain
NCT03535688Phase 2Terminated
- Sponsor
- Northwestern University
- Start
- Mar 2018
- Primary completion
- Feb 2024
- Modality
- Covalent Small Molecules, Classical Binding Small Molecules, Nucleic Acid-Directed Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of d-cycloserine in low back pain (LBP), sponsored by Northwestern University. Started Mar 2018; status: terminated.
02
Drugs
d-cycloserine
03
Conditions
low back pain (LBP)
Beyond the preview
Go deeper on NCT03535688.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03535688.